Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV000675826 | SCV000801548 | uncertain significance | not provided | 2023-01-09 | criteria provided, single submitter | clinical testing | BS1 |
Labcorp Genetics |
RCV001082196 | SCV001108793 | likely benign | Salla disease | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001082196 | SCV001326370 | benign | Salla disease | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001164257 | SCV001326371 | benign | Sialic acid storage disease, severe infantile type | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Breakthrough Genomics, |
RCV000675826 | SCV005222205 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001082196 | SCV001453703 | benign | Salla disease | 2019-12-24 | no assertion criteria provided | clinical testing |